secwatch.observer — SEC 8-K summary
======================================

Issuer:     GOLDENWELL BIOTECH, INC. (GWLL)
CIK:        0001800373
Form:       8-K
Filed at:   2026-09-29T19:29:55+00:00
Accession:  0001477932-26-005892
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Goldenwell Biotech replaces auditor Gillespie & Associates with Privatco CPA; prior reports flagged going concern
--------------------------------------------------------------------------------

- Board approved dismissal of Michael Gillespie & Associates, PLLC on September 27, 2026; engaged Privatco CPA Limited on September 22, 2026, which accepted the appointment.
- Gillespie's reports on FY2025 and FY2024 contained no adverse opinion or disclaimer, but stated substantial doubt about the Company's ability to continue as a going concern.
- No disagreements with Gillespie on accounting principles, financial statement disclosure, or audit scope for FY2025, FY2024, or the interim period; no Item 304(a)(1)(v) reportable events.
- Company had not consulted Privatco on accounting principles, type of audit opinion, or any prior disagreement matter before the engagement.
- Gillespie letter agreeing with the disclosures, dated September 29, 2026, is attached as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800373/000147793226005892/0001477932-26-005892-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800373/000147793226005892/gdwl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-005892

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer